Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Luye Pharma

    Client Virtual Booth

    LUYE PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Luye Pharma
    China Flag
    Country
    Country
    China
    Address
    Address
    22F, Gubei International Fortune Center II, Hongqiao Road 1438, Changning District, Shanghai
    Telephone
    Telephone
    (86)21-6237-6350
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.luye.cn/lvye_en/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Luye Pharma partners with Korea-based Myung In Pharm
    Luye Pharma partners with Korea-based Myung In Pharm

    https://www.biospectrumasia.com/news/25/23688/chinas-luye-pharma-partners-with-korea-based-myung-in-pharm-to-improve-alzheimers-related-dementia-treatment.html

    BIOSPECTRUM ASIA
    07 Feb 2024
    Share Share
    Luye, Duopharma to expand accessibility of cholesterol management products
    Luye, Duopharma to expand accessibility of cholesterol management products

    https://www.biospectrumasia.com/news/25/22232/luye-pharma-duopharma-to-expand-accessibility-of-cholesterol-management-products-in-malaysia.html

    BIOSPECTRUM ASIA
    05 Apr 2023
    Share Share
    US FDA approves Luye Pharma’s schizophrenia treatment Rykindo
    US FDA approves Luye Pharma’s schizophrenia treatment Rykindo

    https://www.pharmaceutical-technology.com/news/fda-schizophrenia-treatment-rykindo/

    PHARMACEUTICAL TECHNOLOGY
    16 Jan 2023
    Share Share
    Luye Pharma enters into new partnership with ICI Pakistan for mental healthcare
    Luye Pharma enters into new partnership with ICI Pakistan for mental healthcare

    https://www.biospectrumasia.com/news/25/21113/luye-pharma-enters-into-new-partnership-with-ici-pakistan-for-mental-healthcare.html

    BIOSPECTRUMASIA
    27 Sep 2022
    Share Share
    Boan Biotech to Present the Pre-clinical Data at World Bispecific Summit
    Boan Biotech to Present the Pre-clinical Data at World Bispecific Summit

    https://www.prnewswire.com/news-releases/boan-biotech-to-present-the-pre-clinical-data-of-its-proprietary-cd3-t-cell-engager-platform-and-ceacd3-bispecific-antibody-at-world-bispecific-summit-301385115.html

    PRNEWSWIRE
    26 Sep 2021
    Share Share
    Boan Biotech to Start PhII Clinical Trial in US Against SARS-CoV-2
    Boan Biotech to Start PhII Clinical Trial in US Against SARS-CoV-2

    https://www.luye.cn/lvye_en/view.php?id=1935

    PRESS RELEASE
    16 Jun 2021
    Share Share
    Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration
    Luye Pharma and Towa Pharmaceutical Enter Strategic Collaboration

    https://en.prnasia.com/releases/apac/luye-pharma-and-towa-pharmaceutical-enter-strategic-collaboration-to-develop-and-commercialize-rivastigmine-multi-day-transdermal-patch-in-japan-308920.shtml

    PRNASIA
    18 Feb 2021
    Share Share
    Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation
    Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation

    https://www.firstwordpharma.com/node/1785980?tsid=5

    FIRSTWORDPHARMA
    22 Dec 2020
    Share Share
    Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation
    Luye Pharma’s Antidepressant Drug LY03005 Completes Primary Endpoint Observation

    https://www.firstwordpharma.com/node/1785980?tsid=5

    FIRSTWORDPHARMA
    22 Dec 2020
    Share Share
    Luye Pharma Starts a Phase III Clinical Study for Denosumab Injection (LY01011)
    Luye Pharma Starts a Phase III Clinical Study for Denosumab Injection (LY01011)

    https://www.luye.cn/lvye_en/view.php?id=1873

    LUYE
    15 Dec 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search